Caruso A, Gelsomino L, Panza S, Accattatis F, Naimo G, Barone I
Biomolecules. 2023; 13(7).
PMID: 37509120
PMC: 10377641.
DOI: 10.3390/biom13071084.
Dincer F, Atmaca H, Akman L, Oktay L, Karaca B, Terek M
PeerJ. 2023; 11:e15246.
PMID: 37155466
PMC: 10122840.
DOI: 10.7717/peerj.15246.
Baczewska M, Bojczuk K, Kolakowski A, Dobroch J, Guzik P, Knapp P
Molecules. 2021; 26(6).
PMID: 33809784
PMC: 8002293.
DOI: 10.3390/molecules26061659.
Olea-Flores M, Juarez-Cruz J, Zuniga-Eulogio M, Acosta E, Garcia-Rodriguez E, Zacapala-Gomez A
Biomolecules. 2020; 10(12).
PMID: 33334030
PMC: 7765557.
DOI: 10.3390/biom10121676.
Mohamed Kamel H, Nassir A, Al Refai A
Cancer Med. 2020; 9(15):5687-5696.
PMID: 32573960
PMC: 7402836.
DOI: 10.1002/cam4.3082.
Leptin Signaling in Liver Tissue of a Transgenic Breast Cancer Mouse Model.
Guvenc Tuna B, Cleary M, Demirel P, Dogan S
Cureus. 2020; 12(1):e6737.
PMID: 32133259
PMC: 7034766.
DOI: 10.7759/cureus.6737.
The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives.
Christodoulatos G, Spyrou N, Kadillari J, Psallida S, Dalamaga M
Curr Obes Rep. 2019; 8(4):413-433.
PMID: 31637624
DOI: 10.1007/s13679-019-00364-y.
Gene expression changes and promoter methylation with the combined effects of estradiol and leptin in uterine tissue of the ovariectomized mice model of menopause.
Shetty A, Venkatesh T, Tsutsumi R, Suresh P
Mol Biol Rep. 2019; 47(1):151-168.
PMID: 31602590
DOI: 10.1007/s11033-019-05116-8.
Gynaecological cancers and leptin: A focus on the endometrium and ovary.
Ray A, Fornsaglio J, Dogan S, Hedau S, Naik D, De A
Facts Views Vis Obgyn. 2018; 10(1):5-18.
PMID: 30510663
PMC: 6260667.
Linking obesity-induced leptin-signaling pathways to common endocrine-related cancers in women.
Nyasani E, Munir I, Perez M, Payne K, Khan S
Endocrine. 2018; 63(1):3-17.
PMID: 30218381
DOI: 10.1007/s12020-018-1748-4.
Classic and Novel Adipocytokines at the Intersection of Obesity and Cancer: Diagnostic and Therapeutic Strategies.
Spyrou N, Avgerinos K, Mantzoros C, Dalamaga M
Curr Obes Rep. 2018; 7(4):260-275.
PMID: 30145771
DOI: 10.1007/s13679-018-0318-7.
Leptin receptor signaling via Janus kinase 2/Signal transducer and activator of transcription 3 impacts on ovarian cancer cell phenotypes.
Kumar J, Fang H, McCulloch D, Crowley T, Ward A
Oncotarget. 2017; 8(55):93530-93540.
PMID: 29212170
PMC: 5706816.
DOI: 10.18632/oncotarget.19873.
Leptin OB3 peptide suppresses leptin-induced signaling and progression in ovarian cancer cells.
Chin Y, Wang L, Hsieh M, Shih Y, Nana A, Changou C
J Biomed Sci. 2017; 24(1):51.
PMID: 28750624
PMC: 5532776.
DOI: 10.1186/s12929-017-0356-6.
Leptin signaling and cancer chemoresistance: Perspectives.
Candelaria P, Rampoldi A, Harbuzariu A, Gonzalez-Perez R
World J Clin Oncol. 2017; 8(2):106-119.
PMID: 28439492
PMC: 5385432.
DOI: 10.5306/wjco.v8.i2.106.
Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation.
Divella R, De Luca R, Abbate I, Naglieri E, Daniele A
J Cancer. 2016; 7(15):2346-2359.
PMID: 27994674
PMC: 5166547.
DOI: 10.7150/jca.16884.
The molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines.
Fiedor E, Gregoraszczuk E
Cancer Chemother Pharmacol. 2016; 78(3):611-22.
PMID: 27480179
PMC: 5010610.
DOI: 10.1007/s00280-016-3113-8.
Downregulation of leptin inhibits growth and induces apoptosis of lung cancer cells via the Notch and JAK/STAT3 signaling pathways.
Zheng X, Yang Z, Dong Y, Zhang G, Sun M, An X
Biol Open. 2016; 5(6):794-800.
PMID: 27185268
PMC: 4920192.
DOI: 10.1242/bio.017798.
Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression.
Gucalp A, Iyengar N, Hudis C, Dannenberg A
Semin Oncol. 2016; 43(1):154-160.
PMID: 26970134
PMC: 4789163.
DOI: 10.1053/j.seminoncol.2015.09.012.
Polymorphisms of Leptin (-2548 G/A) and Leptin Receptor (Q223R) Genes in Iranian Women with Breast Cancer.
Mahmoudi R, Noori Alavicheh B, Nazer Mozaffari M, Fararouei M, Nikseresht M
Int J Genomics. 2015; 2015:132720.
PMID: 26199932
PMC: 4496654.
DOI: 10.1155/2015/132720.
Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women.
Kato S, Abarzua-Catalan L, Trigo C, Delpiano A, Sanhueza C, Garcia K
Oncotarget. 2015; 6(25):21100-19.
PMID: 26053184
PMC: 4673253.
DOI: 10.18632/oncotarget.4228.